Literature DB >> 1601992

Alterations in left ventricular diastolic function in conscious dogs with pacing-induced heart failure.

K Komamura1, R P Shannon, A Pasipoularides, T Ihara, A S Lader, T A Patrick, S P Bishop, S F Vatner.   

Abstract

We investigated in conscious dogs (a) the effects of heart failure induced by chronic rapid ventricular pacing on the sequence of development of left ventricular (LV) diastolic versus systolic dysfunction and (b) whether the changes were load dependent or secondary to alterations in structure. LV systolic and diastolic dysfunction were evident within 24 h after initiation of pacing and occurred in parallel over 3 wk. LV systolic function was reduced at 3 wk, i.e., peak LV dP/dt fell by -1,327 +/- 105 mmHg/s and ejection fraction by -22 +/- 2%. LV diastolic dysfunction also progressed over 3 wk of pacing, i.e., tau increased by +14.0 +/- 2.8 ms and the myocardial stiffness constant by +6.5 +/- 1.4, whereas LV chamber stiffness did not change. These alterations were associated with increases in LV end-systolic (+28.6 +/- 5.7 g/cm2) and LV end-diastolic stresses (+40.4 +/- 5.3 g/cm2). When stresses and heart rate were matched at the same levels in the control and failure states, the increases in tau and myocardial stiffness were no longer observed, whereas LV systolic function remained depressed. There were no increases in connective tissue content in heart failure. Thus, pacing-induced heart failure in conscious dogs is characterized by major alterations in diastolic function which are reversible with normalization of increased loading condition.

Entities:  

Keywords:  NASA Discipline Cardiopulmonary; Non-NASA Center

Mesh:

Year:  1992        PMID: 1601992      PMCID: PMC295881          DOI: 10.1172/JCI115787

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  57 in total

1.  Global and regional diastolic filling dynamics in compensated dilated cardiomyopathy.

Authors:  K Katayama; M Matsuzaki; M Khono; T Fujii; N Ohtani; S Yatabe; H Ogawa; M Ozaki; Y Matsuda; R Kusukawa
Journal:  Jpn Circ J       Date:  1990-06

2.  The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid.

Authors:  J F WOESSNER
Journal:  Arch Biochem Biophys       Date:  1961-05       Impact factor: 4.013

3.  Alterations in myocyte shape and basement membrane attachment with tachycardia-induced heart failure.

Authors:  J L Zellner; F G Spinale; D M Eble; K W Hewett; F A Crawford
Journal:  Circ Res       Date:  1991-09       Impact factor: 17.367

4.  Alterations in myocardial contractility in conscious dogs with dilated cardiomyopathy.

Authors:  R P Shannon; K Komamura; B S Stambler; M Bigaud; W T Manders; S F Vatner
Journal:  Am J Physiol       Date:  1991-06

5.  Congestive heart failure following chronic tachycardia.

Authors:  H N Coleman; R R Taylor; P E Pool; G H Whipple; J W Covell; J Ross; E Braunwald
Journal:  Am Heart J       Date:  1971-06       Impact factor: 4.749

6.  Relation between ventricular and myocyte remodeling with the development and regression of supraventricular tachycardia-induced cardiomyopathy.

Authors:  F G Spinale; J L Zellner; M Tomita; F A Crawford; M R Zile
Journal:  Circ Res       Date:  1991-10       Impact factor: 17.367

7.  Effects of beta-adrenergic stimulation with dobutamine on isovolumic relaxation in the normal and failing human left ventricle.

Authors:  J D Parker; J S Landzberg; J A Bittl; I Mirsky; W S Colucci
Journal:  Circulation       Date:  1991-09       Impact factor: 29.690

8.  Tachycardia-induced cardiomyopathy: effects on blood flow and capillary structure.

Authors:  F G Spinale; J L Zellner; M Tomita; G E Tempel; F A Crawford; M R Zile
Journal:  Am J Physiol       Date:  1991-07

9.  Changes in diastolic cardiac function in developing and stable perinephritic hypertension in conscious dogs.

Authors:  R J Gelpi; A Pasipoularides; A S Lader; T A Patrick; N Chase; L Hittinger; R P Shannon; S P Bishop; S F Vatner
Journal:  Circ Res       Date:  1991-02       Impact factor: 17.367

10.  Changes in left ventricular volume, mass, and function during the development and regression of supraventricular tachycardia-induced cardiomyopathy. Disparity between recovery of systolic versus diastolic function.

Authors:  M Tomita; F G Spinale; F A Crawford; M R Zile
Journal:  Circulation       Date:  1991-02       Impact factor: 29.690

View more
  22 in total

1.  Left ventricular diastolic function after electrical cardioversion of atrial fibrillation.

Authors:  H J Muntinga; F van den Berg; M G Niemeyer; P K Blanksma; E E van der Wall; H J G M Crijns
Journal:  Heart       Date:  2002-04       Impact factor: 5.994

2.  Cardiac myosin activation: a potential therapeutic approach for systolic heart failure.

Authors:  Fady I Malik; James J Hartman; Kathleen A Elias; Bradley P Morgan; Hector Rodriguez; Katjusa Brejc; Robert L Anderson; Sandra H Sueoka; Kenneth H Lee; Jeffrey T Finer; Roman Sakowicz; Ramesh Baliga; David R Cox; Marc Garard; Guillermo Godinez; Raja Kawas; Erica Kraynack; David Lenzi; Pu Ping Lu; Alexander Muci; Congrong Niu; Xiangping Qian; Daniel W Pierce; Maria Pokrovskii; Ion Suehiro; Sheila Sylvester; Todd Tochimoto; Corey Valdez; Wenyue Wang; Tatsuo Katori; David A Kass; You-Tang Shen; Stephen F Vatner; David J Morgans
Journal:  Science       Date:  2011-03-18       Impact factor: 47.728

3.  Omecamtiv Mecarbil, a Cardiac Myosin Activator, Increases Ca2+ Sensitivity in Myofilaments With a Dilated Cardiomyopathy Mutant Tropomyosin E54K.

Authors:  Megan S Utter; David M Ryba; Betty H Li; Beata M Wolska; R John Solaro
Journal:  J Cardiovasc Pharmacol       Date:  2015-10       Impact factor: 3.105

4.  Mechanotransduction Mechanisms for Intraventricular Diastolic Vortex Forces and Myocardial Deformations: Part 2.

Authors:  Ares Pasipoularides
Journal:  J Cardiovasc Transl Res       Date:  2015-05-14       Impact factor: 4.132

Review 5.  Calcific Aortic Valve Disease: Part 1--Molecular Pathogenetic Aspects, Hemodynamics, and Adaptive Feedbacks.

Authors:  Ares Pasipoularides
Journal:  J Cardiovasc Transl Res       Date:  2016-02-18       Impact factor: 4.132

6.  Right ventricular diastolic function in canine models of pressure overload, volume overload, and ischemia.

Authors:  Ares Pasipoularides; Ming Shu; Ashish Shah; Scott Silvestry; Donald D Glower
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-11       Impact factor: 4.733

7.  Know Me! Unraveling the Riddle of Calcific Aortic Valve Disease by Bioinformatics.

Authors:  Ares Pasipoularides
Journal:  Tohoku J Exp Med       Date:  2017-12       Impact factor: 1.848

Review 8.  Comorbidity of atrial fibrillation and heart failure.

Authors:  Liang-Han Ling; Peter M Kistler; Jonathan M Kalman; Richard J Schilling; Ross J Hunter
Journal:  Nat Rev Cardiol       Date:  2015-12-10       Impact factor: 32.419

Review 9.  Calcific Aortic Valve Disease: Part 2-Morphomechanical Abnormalities, Gene Reexpression, and Gender Effects on Ventricular Hypertrophy and Its Reversibility.

Authors:  Ares Pasipoularides
Journal:  J Cardiovasc Transl Res       Date:  2016-05-16       Impact factor: 4.132

10.  Myocardial beta-adrenergic receptor function during the development of pacing-induced heart failure.

Authors:  K Kiuchi; R P Shannon; K Komamura; D J Cohen; C Bianchi; C J Homcy; S F Vatner; D E Vatner
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.